Tectonic Therapeutic (TECX) Return on Invested Capital (2025)

Tectonic Therapeutic (TECX) reported Return on Invested Capital of 0.01% for Q4 2025, up 526.74% quarter-over-quarter from 0.0% in Q3 2025.

Tectonic Therapeutic (TECX) Return on Invested Capital (2025) Analysis & Trends

Tectonic Therapeutic (TECX) has 1 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2025.

Return on Invested Capital for Q4 2025 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01% (changed N/A YoY), and the FY2025 annual result was 0.02%, changed N/A from the prior year.
Return on Invested Capital grew to 0.01% in Q4 2025 per TECX's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Invested Capital peaked at 0.01% in Q4 2025 and troughed at 0.0% in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	0.01%
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-0.01%
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	-0.01%
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	0.00%
9	Abivax	91.71 Bn	91.71 Bn	-	-
10	Tectonic Therapeutic	528.16 Mn	291.27 Mn	-	-

Download Data